Dynorphin B activated opioid receptors directly on the cell nucleus (not just the surface), triggering nuclear PKC signaling that activated cardiac transcription factors and promoted heart cell development from embryonic stem cells.
Nuclear opioid receptorsOpioid signaling doesn't stop at the cell surface — dynorphin B activates receptors on the NUCLEUS to directly control cardiac gene programs
What the researchers found
Dynorphin B activated nuclear opioid receptors coupling to nuclear PKC activation, which induced cardiac transcription factors (GATA-4, Nkx-2.5) for cardiogenesis in embryonic stem cells — a novel nuclear signaling mechanism.
Why it matters
Nuclear opioid receptors are a new signaling paradigm. If opioid peptides directly control gene expression through nuclear receptors, their effects are more fundamental and long-lasting than surface receptor signaling alone.
How the study worked
In-vitro study using embryonic stem cells. Nuclear opioid receptor activation by dynorphin B, nuclear PKC signaling, and cardiac gene expression measured with subcellular fractionation.
What this study cannot tell us
In-vitro stem cell model. Nuclear opioid receptor signaling in mature cardiac tissue needs confirmation.
How to read the evidence
Preliminary in-vitro evidence with novel subcellular signaling characterization in stem cells.
When this study was published
Published in 2003. Nuclear opioid receptor signaling has been further characterized as a distinct signaling modality.
The bigger picture
Opioid signaling isn't just about fast cell-surface receptor events — it reaches into the nucleus to control gene programs. This adds a new dimension to understanding how opioid peptides regulate cell fate.
Questions still open
- Do nuclear opioid receptors function in adult heart cells?
- Could nuclear opioid signaling be therapeutically targeted?
- Does this mechanism explain opioid drugs' cardiac effects?
Common questions
Can opioids signal inside the cell nucleus?
Is this relevant to heart repair?
Read the original research
Dynorphin B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells.
Circulation research, 92(6), 623-9
Citation
Ventura, Carlo; Zinellu, Elisabetta; Maninchedda, Emiliana; Maioli, Margherita. (2003). Dynorphin B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells.. Circulation research, 92(6), 623-9.